These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7658816)

  • 61. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
    Reeves MF; Monmaney JA; Creinin MD
    Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion.
    Dunn S; Panjwani D; Gupta M; Meaney C; Morgan R; Feuerstein E
    Contraception; 2015 Sep; 92(3):220-6. PubMed ID: 26068140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh.
    Alam A; Bracken H; Johnston HB; Raghavan S; Islam N; Winikoff B; Reichenbach L
    Int Perspect Sex Reprod Health; 2013 Jun; 39(2):79-87. PubMed ID: 23895884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Misoprostol used alone for the termination of early pregnancy. A review of the evidence.
    Blanchard K; Winikoff B; Ellertson C
    Contraception; 1999 Apr; 59(4):209-17. PubMed ID: 10457864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Issues in second trimester induced abortion (medical/surgical methods).
    Lee VC; Ng EH; Ho PC
    Best Pract Res Clin Obstet Gynaecol; 2010 Aug; 24(4):517-27. PubMed ID: 20347397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial.
    Creinin MD; Vittinghoff E
    JAMA; 1994 Oct; 272(15):1190-5. PubMed ID: 7523739
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa.
    Lince-Deroche N; Constant D; Harries J; Kluge J; Blanchard K; Sinanovic E; Grossman D
    PLoS One; 2018; 13(6):e0197485. PubMed ID: 29953434
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia.
    Murthy A; Creinin MD
    Expert Opin Pharmacother; 2003 Apr; 4(4):503-13. PubMed ID: 12667113
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The many faces of RU486: tales of situated knowledges and technological contestations.
    Clarke A; Montini T
    Sci Technol Human Values; 1993; 18(1):42-78. PubMed ID: 11652075
    [No Abstract]   [Full Text] [Related]  

  • 72. Toward safe and effective medical abortion.
    Ewart WR; Winikoff B
    Science; 1998 Jul; 281(5376):520-1. PubMed ID: 9705721
    [No Abstract]   [Full Text] [Related]  

  • 73. Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion.
    Creinin MD
    Contraception; 2000 Sep; 62(3):117-24. PubMed ID: 11124358
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Misoprostol and illegal abortion in Fortaleza, Brazil.
    Coêlho HL; Teixeira AC; Santos AP; Forte EB; Morais SM; La Vecchia C; Tognoni G; Herxheimer A
    Lancet; 1993 May; 341(8855):1261-3. PubMed ID: 8098403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of failure in medical abortion.
    Winikoff B; Ellertson C; Clark S
    Contraception; 1996 Dec; 54(6):323-7. PubMed ID: 8968659
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studying the acceptability and feasibility of medical abortion.
    Winikoff B; Coyaji K; Cabezas E; Coyaji B; Krishna U; de la Concepcion O; Eschen A; Sivin I; Brady M
    Law Med Health Care; 1992; 20(3):195-8. PubMed ID: 1434760
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Toxicity of abortifacients: A review for physicians in the post roe era.
    Mazer-Amirshahi M; Ye P
    Am J Emerg Med; 2022 Nov; 61():7-11. PubMed ID: 36007432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acceptability of mifepristone for early pregnancy interruption.
    David HP
    Law Med Health Care; 1992; 20(3):188-94. PubMed ID: 11643042
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Medical abortion: public health and private lives.
    Grimes DA
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S1-2. PubMed ID: 10944363
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RU 486, the FDA and free enterprise.
    Buc NL
    Law Med Health Care; 1992; 20(3):224-5. PubMed ID: 1434765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.